Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 88101-88150 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05335317
Treatment of Vaginal Atrophy With Low Intensity Nanosecond Neodymium Laser
NA
Recruiting
120 participants
Started: Apr 18, 2022 · Completed: Dec 1, 2025
3 conditions
1 sponsor
1 location
NCT05344001
Life After Sport: Prior Injury and Sedentary Behavior as Mechanisms of Later Poor Health
N/A
Recruiting
450 participants
Started: Apr 18, 2022 · Completed: Aug 31, 2027
4 conditions
2 sponsors
1 location
NCT06523114
Transcatheter Arterial Embolization for Elbow and Foot Plantar Pain
NA
Recruiting
13 participants
Started: Apr 18, 2022 · Completed: Aug 31, 2025
6 conditions
2 sponsors
1 location
NCT06833541
Research on Gut Microbiota and Metabolomics in Diabetic Kidney Disease
N/A
Recruiting
720 participants
Started: Apr 18, 2022 · Completed: Dec 1, 2025
3 conditions
2 sponsors
1 location
NCT06261229
The Effectiveness of Intermittent Fasting and Behavioral Economics Intervention on Weight Control in Obese Patients
NA
Enrolling by invitation
123 participants
Started: Apr 18, 2022 · Completed: Jun 30, 2024
5 conditions
2 sponsors
1 location
NCT05342792
Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma
PHASE3
Recruiting
556 participants
Started: Apr 17, 2022 · Completed: Jun 30, 2029
1 condition
13 sponsors
1 location
NCT05221229
Outcome of Overweight AF Patients Following Ablation With a Potential Weight Loss Medication ( GOAL-AF )
N/A
Active, not recruiting
29 participants
Started: Apr 17, 2022 · Completed: Jun 1, 2026
4 conditions
2 sponsors
1 location
NCT05232409
Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic Cancer
PHASE1
Recruiting
72 participants
Started: Apr 17, 2022 · Completed: Mar 31, 2026
2 conditions
1 sponsor
1 location
NCT05696977
Effect of Obesity on Cyclosporine Blood Trough Level in Nephrotic Syndrome Patients
PHASE4
Recruiting
74 participants
Started: Apr 17, 2022 · Completed: Apr 30, 2024
1 condition
1 sponsor
1 location
NCT05306080
Tadekinig Alfa (IL-18BP) Rescue Therapy for CAR T Cell Related Cytokine Release Syndrome (CRS) and HLH-like Syndrome
EARLY_PHASE1
Recruiting
10 participants
Started: Apr 17, 2022 · Completed: Apr 30, 2026
2 conditions
1 sponsor
1 location
NCT05318755
China Gender-affirming Hormone Therapy Study
N/A
Recruiting
240 participants
Started: Apr 16, 2022 · Completed: Dec 31, 2028
2 conditions
2 sponsors
1 location
NCT05328401
To Evaluate the Therapeutic Effect of Laser Acupuncture in Patients with Acute or Subacute Post Stroke Shoulder Pain
NA
Recruiting
58 participants
Started: Apr 16, 2022 · Completed: Mar 15, 2028
1 condition
1 sponsor
1 location
NCT04988724
Impact of Physical Exercise at a Hospital
NA
Recruiting
700 participants
Started: Apr 16, 2022 · Completed: Dec 31, 2026
3 conditions
1 sponsor
2 locations
NCT05313464
Effect of Parental Enteral Nutrition on Quality Of Parent-Child Interactions
NA
Enrolling by invitation
42 participants
Started: Apr 15, 2022 · Completed: Dec 28, 2027
2 conditions
2 sponsors
1 location
NCT05957887
Short and Intermediate Term Effect of Dapagliflozin on Left Ventricular Remodeling in Anterior STEMI Patients
PHASE3
Recruiting
120 participants
Started: Apr 15, 2022 · Completed: Apr 15, 2025
1 condition
1 sponsor
1 location
NCT05332691
Transapical Beating-heart Septal Myectomy in Patient With Hypertrophic Obstructive Cardiomyopathy
NA
Recruiting
1,000 participants
Started: Apr 15, 2022 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05272241
Registry of Asthma Characterization and Recruitment 3 (RACR3)
N/A
Recruiting
1,500 participants
Started: Apr 15, 2022 · Completed: May 31, 2028
1 condition
1 sponsor
7 locations
NCT05322733
Orelabrutinib and Obinutuzumab Plus FC Regimen in Treating Newly Diagnosed CLL/SLL
PHASE2
Recruiting
25 participants
Started: Apr 15, 2022 · Completed: Nov 5, 2025
1 condition
1 sponsor
1 location
NCT06294782
PrOsPective Cohort Study for STereotactic Arhythmia Radioablation (STAR) of Refractory Ventricular Tachycardia
NA
Recruiting
30 participants
Started: Apr 15, 2022 · Completed: Feb 28, 2025
1 condition
4 sponsors
1 location
NCT05294367
Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma
EARLY_PHASE1
Recruiting
60 participants
Started: Apr 15, 2022 · Completed: Apr 1, 2027
1 condition
2 sponsors
1 location
NCT05324332
68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer Patients
NA
Recruiting
50 participants
Started: Apr 15, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05370599
Hypertension in Young Adults Trial
PHASE2
Active, not recruiting
120 participants
Started: Apr 15, 2022 · Completed: May 1, 2027
1 condition
1 sponsor
1 location
NCT05359848
A Pilot, Feasibility Study of Intermittent Caloric Restriction Plus Plant-based Diet in Cancer Patients Receiving Chemotherapy
NA
Recruiting
30 participants
Started: Apr 15, 2022 · Completed: Jun 1, 2026
3 conditions
1 sponsor
2 locations
NCT05388331
RIS International Cohort
N/A
Recruiting
1,000 participants
Started: Apr 15, 2022 · Completed: Apr 15, 2029
2 conditions
1 sponsor
1 location
NCT05180435
Dietary Approaches for Cardiovascular Health Study
NA
Active, not recruiting
42 participants
Started: Apr 15, 2022 · Completed: May 31, 2025
1 condition
2 sponsors
1 location
NCT05280457
HPV 16-positive and/or HPV 18-positive Recurrent and/or For Patients With Metastatic Head and Neck Cancer to Evaluate GX-188E DNA Vaccination, GX-I7 and Nivolumab Combination Therapy
PHASE2
Recruiting
21 participants
Started: Apr 15, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT05177536
Iberdomide Maintenance Therapy in Patients With Multiple Myeloma
PHASE2
Active, not recruiting
40 participants
Started: Apr 15, 2022 · Completed: Jan 31, 2031
1 condition
1 sponsor
2 locations
NCT05113160
Conversation Group Treatment for Aphasia: Does it Work?
NA
Active, not recruiting
162 participants
Started: Apr 15, 2022 · Completed: Apr 30, 2026
1 condition
3 sponsors
3 locations
NCT05396560
Fecal Immunochemical Test for Post-polypectomy Surveillance to Reduce Unnecessary eNdoscopy
N/A
Recruiting
3,000 participants
Started: Apr 15, 2022 · Completed: Apr 15, 2027
1 condition
1 sponsor
1 location
NCT05341206
Evaluation the Effects of Herbal Gargle for Chemoradiotherapy-induced Oral Mucositis of Head & Neck Cancer, a Pilot Study.
PHASE2
Not yet recruiting
80 participants
Started: Apr 15, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT05201547
Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line
PHASE3
Active, not recruiting
260 participants
Started: Apr 15, 2022 · Completed: Oct 31, 2029
1 condition
2 sponsors
100 locations
NCT05325996
Evaluating Home Testing Devices for the Management of Glaucoma
NA
Recruiting
50 participants
Started: Apr 15, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05012124
Using Technology to Optimize Collaborative Care Management of Depression in Urban and Rural Cancer Centers, SCOPE
NA
Active, not recruiting
297 participants
Started: Apr 15, 2022 · Completed: Mar 31, 2026
3 conditions
2 sponsors
4 locations
NCT04098354
Telemonitoring of Hypertensive Patients With Chronic Kidney Disease
NA
Recruiting
146 participants
Started: Apr 15, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04214210
The DIALOGUE Study: Swiss-Korean Billateral Collaboration
NA
Recruiting
228 participants
Started: Apr 15, 2022 · Completed: Dec 31, 2025
3 conditions
18 sponsors
8 locations
NCT05333367
MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy
NA
Recruiting
20 participants
Started: Apr 15, 2022 · Completed: Jul 31, 2025
3 conditions
1 sponsor
1 location
NCT05206513
Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy
PHASE3
Active, not recruiting
86 participants
Started: Apr 15, 2022 · Completed: Jun 30, 2026
2 conditions
1 sponsor
38 locations
NCT06004349
Autoimmune and Autoinflammatory Genetics Study
N/A
Recruiting
1,500 participants
Started: Apr 15, 2022 · Completed: Apr 5, 2032
4 conditions
1 sponsor
2 locations
NCT05463523
A Multi-centric Clinical Trial in China for Skin Diseases Intelligent Diagnosis and Treatment System
N/A
Recruiting
200 participants
Started: Apr 15, 2022 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT05401162
Chemotherapy Supported by Autologous Hematopoietic Stem Cells
NA
Recruiting
40 participants
Started: Apr 15, 2022 · Completed: May 31, 2027
1 condition
1 sponsor
1 location
NCT05180695
HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue Sarcomas
PHASE1/PHASE2
Recruiting
58 participants
Started: Apr 15, 2022 · Completed: Jul 31, 2026
2 conditions
3 sponsors
5 locations
NCT06706713
Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer
PHASE2
Recruiting
200 participants
Started: Apr 15, 2022 · Completed: Jun 30, 2026
2 conditions
1 sponsor
2 locations
NCT06591299
Combining Aspirin With Cilostazol or Clopidogrel in Minor Stroke or TIA
PHASE3
Recruiting
870 participants
Started: Apr 15, 2022 · Completed: Sep 30, 2024
1 condition
1 sponsor
1 location
NCT05283577
Electroacupuncture for the Management of Symptom Clusters in Cancer Patients and Survivors
NA
Active, not recruiting
70 participants
Started: Apr 15, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05374577
Pulmonary Vascular Dysfunction as a Cause of Persistent Exertional Dyspnea After Coronavirus Disease (COVID-19)
N/A
Active, not recruiting
200 participants
Started: Apr 15, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05151172
EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial)
NA
Active, not recruiting
530 participants
Started: Apr 15, 2022 · Completed: Jun 30, 2026
1 condition
2 sponsors
53 locations
NCT05176704
Development and Validation of a Novel Functional Eye-Tracking Software Application for Alzheimer's Disease
N/A
Recruiting
250 participants
Started: Apr 15, 2022 · Completed: Mar 3, 2024
1 condition
1 sponsor
1 location
NCT05248035
PupillOmetry for Prediction of DelirIUM
N/A
Active, not recruiting
213 participants
Started: Apr 15, 2022 · Completed: Jun 30, 2025
2 conditions
1 sponsor
1 location
NCT06706063
Ultrasonograpy in Hemiplegic Patients
N/A
Active, not recruiting
100 participants
Started: Apr 15, 2022 · Completed: Jun 15, 2025
3 conditions
1 sponsor
1 location
NCT05209230
Is Myocardial Stunning Induced by Continuous Renal Replacement Therapy a Reality in Critically Ill Patients?
NA
Recruiting
42 participants
Started: Apr 15, 2022 · Completed: Jan 16, 2026
3 conditions
1 sponsor
3 locations
Previous
1
More pages
1760
1761
1762
1763
1764
1765
1766
More pages
2369
Next